Last reviewed · How we verify
NCT07428343
Effects of Tai Chi Exercises on Patients Functional Status With Knee Osteoarthritis
NA trial testing Tai Chi training in OA Knee in 96 participants. Completed in 13 June 2025.
13 June 2025
Quick facts
| Lead sponsor | Grzegorz Mańko |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 96 |
| Start date | 9 May 2025 |
| Primary completion | 13 June 2025 |
| Estimated completion | 13 June 2025 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Tai Chi training
- Comprehensive Inpatient Physiotherapy with other standard therapies
- Kinect-Based Virtual Reality Balance Training with Biofeedback
Conditions studied
- OA Knee — all drugs for OA Knee →
Sponsor
Grzegorz Mańko
Who can join
Adults 60 to 80, any sex, with OA Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Brief summary The goal of this clinical trial is to evaluate whether Tai Chi exercise, used as an adjunct to standard physiotherapy, can improve balance, functional status, pain, and knee joint mobility in older adults (65-75 years) diagnosed with knee osteoarthritis (gonarthrosis), compared with standard physiotherapy alone and physiotherapy combined with virtual reality-based training. The main questions it aims to answer are: Does adding Tai Chi to standard physiotherapy lead to greater improvements in static and dynamic balance (Berg Balance Scale, Timed Up and Go test) in patients with knee osteoarthritis? Does Tai Chi result in superior improvements in pain intensity (VAS), functional status (WOMAC), and knee joint range of motion compared with standard physiotherapy and VR-based training? Researchers will compare three intervention arms-standard physiotherapy, standard physiotherapy plus virtual reality (Kinect-based biofeedback training), and standard physiotherapy plus Tai Chi-to determine whether Tai Chi provides greater clinical and functional benefits than the other rehabilitation approaches. Participants will: Receive standard inpatient physiotherapy for knee osteoarthritis Additionally perform one of the following interventions for 30 minutes daily over 4 weeks: Tai Chi exercises led by a qualified therapist, focusing on balance, controlled movement, and pain-free execution Virtual reality-based balance training using a Kinect system Undergo assessments before and after the intervention period, including pain, balance, functional performance, and knee joint mobility measures
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07428343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tai Chi training
Trials testing the same drug.
- NCT06967909 — Effectiveness of Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes: A Non-Inferiority · NA · not yet recruiting
- NCT06682897 — Simplified Tai Chi Exercises to Improve Function in People With Chronic Ankle Instability · NA · completed
- NCT05690737 — Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration · NA · recruiting
- NCT04248400 — Effectiveness of Tai Chi to Improve Cognitive Function in Older Adults With Mild Cognitive Impairment · NA · completed
- NCT05447975 — A Prospective Cohort Study of Exercise Rehabilitation in the Treatment of Parkinson's Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07428343 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Grzegorz Mańko
- Last refreshed: 23 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07428343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing